According to ROC analysis, the overall results demonstrated that BHLHE40 and DDIT4 expression in PBMCs represented potential diagnostic biomarkers in distinguishing HCC from the non-HCC group. The gene discussed is DDIT4; the disease is hepatocellular carcinoma.